In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $83.54 down -1.51% from its previous closing price of $84.82. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.53 million shares were traded. AXSM stock price reached its highest trading level at $85.57 during the session, while it also had its lowest trading level at $81.85.
Ratios:
For a deeper understanding of Axsome Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.40 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on September 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $140.
On August 06, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $95 to $106.
On July 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $130.Needham initiated its Buy rating on July 22, 2024, with a $130 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 11 ’24 when Saad Mark E sold 11,016 shares for $91.31 per share. The transaction valued at 1,005,871 led to the insider holds 10,002 shares of the business.
Saad Mark E bought 11,016 shares of AXSM for $1,005,843 on Sep 11 ’24. On Aug 09 ’24, another insider, Jacobson Mark L., who serves as the Chief Operating Officer of the company, sold 47,739 shares for $84.26 each. As a result, the insider received 4,022,488 and left with 5,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 4009936640 and an Enterprise Value of 3886080000. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.76 while its Price-to-Book (P/B) ratio in mrq is 38.83. Its current Enterprise Value per Revenue stands at 13.332 whereas that against EBITDA is -14.867.
Stock Price History:
Over the past 52 weeks, AXSM has reached a high of $98.40, while it has fallen to a 52-week low of $55.02. The 50-Day Moving Average of the stock is -6.06%, while the 200-Day Moving Average is calculated to be 1.98%.
Shares Statistics:
For the past three months, AXSM has traded an average of 483.81K shares per day and 441990 over the past ten days. A total of 47.35M shares are outstanding, with a floating share count of 39.16M. Insiders hold about 18.41% of the company’s shares, while institutions hold 84.18% stake in the company. Shares short for AXSM as of 1726185600 were 7671607 with a Short Ratio of 15.86, compared to 1723680000 on 7665579. Therefore, it implies a Short% of Shares Outstanding of 7671607 and a Short% of Float of 19.18.
